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1. Introduction 
In this chapter, we review the different magnetic resonance imaging (MRI)-based methods 
used to quantify whole and subcortical brain structures volume, and discuss the relevance 
of the brain atrophy in different neurodegenerative disseases. Although there are a lot of 
studies for multiple sclerosis (MS) and dementia of Alzheimer’s type (AD) for the brain 
atrophy using different methods, the optimal method for quantifying atrophy has not been 
established to date.  
In recent years, computed tomography (CT) scanning has been replaced with MRI scanning 
due to its enhanced soft-tissue resolution, especially for cerebrospinal fluid (CSF)-filled 
spaces, such as ventricular enlargement in patients with AD. Thus, a transition has occurred 
from CT to MRI in longitudinal studies investigating the human brain. As a result of 
development of new neuroimaging methods in clinical practice, volumetric methods started 
to be more sophisticated depending on various imaging methods (Lim et al., 2000). There 
are numerous reasons for the aforementioned transition; first of all, unlike CT, MRI has no 
inherent radiation effect, and secondly, CT underestimates cortical sulcal volume relative to 
MRI due to poorer resolution and spectral shift artifact on CT (Lim et al., 2000). Due to 
higher contrast resolution, MRI can better characterize the brain morphology including the 
size, tissue composition such as gray (or grey) matter and white matter, and shape of 
different cortical or subcortical neuroanatomic structures (Lim et al., 2000). Nowadays, it is 
possible to use MRI to visualize and quantify the directional coherence of white matter 
fibers, called diffusion tensor imaging (DTI), for investigation of connectivity and 
disconnectivity between different brain regions (Basser et al., 1994). Additionally, MRI 
equipments are also used to provide functional brain responses with functional MRI (fMRI) 
and perfusion MRI as in some nuclear medicine neuroimaging methods such as positron 
emission tomography (PET) and single photon emission computed tomography (SPECT). 
These methods can provide pathognomonic data of certain structural lesions in AD, as they 
can demonstrate neuronal activity or receptor characteristics (Small, 2002). High field MRI 
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has started to further depict the regional atrophy patterns AD and other neurodegenerative 
disorders. 
In this chapter, we aim to overview the challenging and exciting radiological methods used 
for the diagnosis of various neurodegenerative diseases. Specifically, we focus on the 
neuroimaging techniques in the first part of the chapter, their clinical applications in the 
second part, and methods for volume estimation including stereological techniques on the 
last part of the text.  
2. Neuroimaging techniques 
Primary neuroimaging techniques that are widely used clinically are CT, PET, SPECT, 
conventional MRI, fMRI, magnetic resonance spectroscopy (MRS), and tractography or DTI. 
These techniques enlighten different aspects of brain structures or functions (Frey et al., 
1999; Small, 2002). An overview of the neuroimaging techniques is following:  
2.1 Computed tomography (CT) 
CT is the first imaging modality to provide in vivo evidence of the brain atrophy in different 
neurodegenerative diseases. CT images are generated by passing an x–ray beam through the 
skull or other object (e.g. spine and vertebral column) and it measures the attenuation of an 
x-ray beam through different body tissues e.g. brain, bone and CSF. Therefore, tissue’s 
appearance will vary according to degree of its attenuation (Frey et al., 1999). The degree of 
attenuation can be measured numerically as a tissue density number for each voxel (volume 
element) and then these numbers can be converted to gray scale values and presented 
visually as pixels (Frey et al., 1999). Among different body tissues, the bone has the highest 
attenuation and appears white on CT images (Small, 2002). On the other hand, CT study has 
some limitations such as radiation hazards, inability to differentiate gray and white matter 
due to low contrast resolution and visualization of the posterior fossa structures, particularly 
brain stem and cerebellum. Despite to these limitations, quantitative CT still can demonstrate 
the presence of greater brain atrophy and ventricular dilatation in patients with AD 
compared with controls (Creasey et al., 1986). 
2.2 Single photon emission computed tomography (SPECT) 
In SPECT, the scanner determines the site of the photon source following adminstration of 
an unstable isotope or inhaled/injected tracer and thus an image reflecting cerebral blood 
flow or receptor distribution is produced (Schuckit et al., 1992). Unfortunately, its spatial 
resolution is not high enough for imaging deep structures and determination of the source 
of single photon emitters is difficult (Small, 2002).  
2.3 Positron emission tomography (PET) 
A PET scanner determines the line along which the photons travel, by recording the 
simultaneous arrival of two different photons at different detectors, and an image is then 
constructed from information received by the scanner. Importantly, PET study demonstrates 
receptor characteristics like density and affinity following injection of receptor ligands 
labeled with nuclides, in addition to cerebral blood flow. In patients with AD, PET studies 
using fluorodeoxyglucose have revealed characteristic alterations in cerebral blood flow and 
metabolism in the parietal, temporal and prefrontal cortices (Mazziotta et al., 1992).  
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2.4 Conventional magnetic resonance imaging (MRI) 
The MRI scanner detects the radiofrequency energy emitted and energy level changes 
represent different brain structures. Typically, T1-weighted images differentiate gray and 
white matter, while T2-weighted images delineate white matter hyperintensities. It is reported 
that spatial resolution for MRI is 1 to 2 mm, less than that of CT (Small, 2002). Fortunately, 
patients can have multiple MRI scans because it does not involve ionizing radiation. In MRI 
study, the object is placed in a high field strength magnetic field varying from 0.5 to 3 Tesla 
(T). Technically, different relaxation times, in addition to proton density, are measured and 
further manipulations by using various pulse sequences are possible. Today, various MRI 
techniques such as fast spin echo, high performance gradients, echo planar and diffusion 
weighted imaging are available for clinical use, in addition to MRI contrast agents, CSF 
velocity analysis, and interventional MRI (Bradley & Bydder, 1997). Recently, some technical 
improvements regarding the acquisition and processing of structural data have provided 
vivid visual representations of the external surface and internal structures of the human 
brain (Lim et al., 2000). Clinically, the progressive neuronal loss leading to atrophy in 
neurodegenerative disease increases the value of MRI (Loewe et al., 2002). 
2.5 Functional magnetic resonance imaging (fMRI) 
With recent developments in MRI techniques, it is also possible to measure brain activity 
and tissue signal changes, reflecting local changes in oxygenation of haemoglobin, which 
depend on regional blood perfusion. Technical point of view, the signal intensity of 
deoxygenated hemoglobin differs from that of oxygenated hemoglobin (Belliveau et al., 
1992). This MRI method also called BOLD technique. As a rule, the brain tissue during brain 
activity does not use this excess oxygen, causing high concentration of oxygenated blood, 
greater levels of magnetic field homogeneity and higher MRI signal intensity (Wagner et al., 
1998). Thus, brain regions receiving greater blood flow during brain activity produce a 
stronger MRI signal than do other regions and areas of relative brain activity can be easily 
detected (Small, 2002).  
2.6 Diffusion tensor imaging (DTI) 
DTI provides detailed information concerning the anatomy of white matter structure in the 
central nervous system. With use of DTI, visualizations of projections of axonal fibers, i.e. 
neuronal connectivity, is possible by quantitative evaluation on the anisotropy of water 
diffusion, local fiber orientation and integrity of white matter tracks (Jones et al., 1999). 
Technically, DTI visualizes diffusional anisotropy within each voxel as three-dimensional 
projections of axonal fibers. In patients with AD and other neuropsychiatric disorders, the 
degree of neuronal connectivity loss is a useful marker in the progression of the disease 
(Buchsbaum et al., 1998; Ewers et al., 2011). Moreover, recent studies revealed the presence 
of loss of myelin and axons in patients with AD, particularly periventricular areas (Hanyu et 
al., 1997; Ewers et al., 2011).  
2.7 Magnetic resonance spectroscopy (MRS) 
From the technical view, the magnetic resonance spectrum display according to frequency 
shows different chemical forms of the element such as characteristic peaks, thus reflecting 
tissue metabolite concentrations (Weiner, 1987; Bothwell & Griffin 2011). As a noninvasive 
study, MRS provides quantitative regional biochemical and physiologic features of the 
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tissue. To determine N-acetylaspartate (NAA) content of hippocampus in patients with AD, 
some authors used proton MRS (1H MRS) and volumetric MRI (Weiner, 1987; Schuff et al. 
1997). 
2.8 Improvements in magnetic resonance imaging 
2.8.1 Mechanisms of tissue contrast: Pulse sequences 
By varying elements of the image acquisition sequence of MRI, it is possible to manipulate 
the amount of contrast between various tissues. It is well-known that hydrogen atoms are 
the most important element of the tissue and MRI device demonstrate signals related with 
free water. Based on proton density and relaxation time of any tissue, different structures 
will appear in an acquired image. T1 means the time taken for excited nuclei to return to 
equilibrium, while T2 is an xponential time constant related with the time for the excited 
nuclei to lose signal (Lim et al., 2000). Technical view of point, the time between 
radiofrequency pulses (TR) and the amount of time after the pulse called echo time (TE) are 
important parameters; a long TR and a long TE give T2-weighted image, while a short TR 
and a short TE gives T1-weighted image. Although T1-weighted spin-echo and inversion 
recovery sequences have poor definition of CSF/skull margins for reliably measuring 
intracranial volume, they are used for morphometric studies because they provide good 
white-gray contrast (Lim et al., 2000). 
Sources of contrast other than that based on manipulation of T1, T2, fluid-attenuated 
inversion recovery (FLAIR) and proton density are used to obtain further information. T1-
weighted images are superior to T2-weighted images for the evaluation of atrophy, because 
T2-weighted ones overestimate the dimensions of ventricles and sulci (Kucharczyk & 
Henkelman, 1994). On the other hand, T1-weighted imaging gives a clear distinction 
between grey matter, white matter and CSF; therefore, they are used for quantitative MRI 
studies of brain morphology, particularly of individual brain structures (Keller & Roberts, 
2009) (Fig. 1). 
Fast spin echo T2 sequences has been usually used in brain imaging due to their short 
acquisition time and increased robustness to motion artifacts. In imaging of 
neurodegenerative disorders like Parkinson-like syndromes, however, gradient echo T2-
weighted spin-echo sequences are preferred because they increase the sensitivity for 
paramagnetic materials (ferritin, melanin etc.). Also, proton-density or FLAIR sequences 
identify gliosis owing to result of progressive neuronal loss (Loewe et al., 2002). Therefore, 
T2-weighted imaging may be used for determination of intracranial volume as the increased 
signal intensity of CSF provides better determination of CSF and the parenchyma of the 
brain (Keller & Roberts, 2009). Therefore, the type of MRI sequence used is important for 
volume estimation. 
2.8.2 Two-dimensional multi-slice and three-dimensional imaging 
Two-dimensional (2D) images are obtained in axial, sagittal and coronal planes (Fig. 1). 
Image orientation, giving a different view of the brain with optimal visualization of different 
structures, is described according to radiofrequency pulse excitations and the magnetic 
gradients in three orthogonal axes. Basically, a mid-sagittal section provides an image of the 
corpus callosum and the prefrontal cortex, coronal section gives an image of the limbic 
structures including hippocampus, and axial section gives an image of basal ganglia 
structures and the lateral ventricular system.  
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It is important to know that 2D image has a limitation so that only selected slices imaged 
and therefore a comparison across subjects is difficult, although it may be possible by 
orienting each slice acquisition relative to a specific anatomic plane. On the other hand, 
three-dimensional (3D) volume acquisition protocols include the entire brain and they are 
widely used in psychiatric neuroimaging. Using T1-weighted MRI sections with a good 
gray/white matter differentiation, the entire brain with 1.5 mm or thinner slices are 
obtained in 10 minutes or less. As a rule, an in-plane resolution of 1 mm means that each 
pixel in the image matrix represents 1 mm2 (Lim et al., 2000). 
Quantitative investigations of the brain using MRI may reveal important information about 
the function and organisation of the brain being studied, recently. MRI has become the 
method of choice for the examination of macroscopic neuroanatomy in vivo due to excellent 
levels of image resolution and between tissue contrasts. Estimation of brain compartment 
volume needs high resolution MRIs for the delineation of anatomical boundaries. With the 
use of higher magnetic field strength, a better image quality with can be obtained using 
thinner slices and shorter imaging time. For this reason, many researchers frequently use 
MRI scanners which are either with 1.5 T or 3 T systems (Fig. 2). Although 3 T systems offer 
increased resolution of between-tissue contrast (i.e. increased visualisation of the borders 
between gray matter, white matter and CSF), MRI scans on 1.5 T systems are sufficient for 
the quantification of relatively small brain structures, such as the hippocampus, amygdala, 
and deep gray matter nuclei (Keller & Roberts, 2009). 
3. Clinical applications 
3.1 Dementia syndromes 
A number of studies reported that patients with MS have smaller volumes of the 
parenchyma than in age-matched control subjects (Bermel et al., 2003; Sanfilipo et al., 2005, 
2006). The first method used for the estimation of brain atrophy is linear measurement of 
ventricles or other brain structural dimensions (Smith et al., 2002). In general, MRI studies 
reveal some differences in the volume of the brain structures in certain neurodegenerative 
diseases, an inhomogeneous group of neurological diseases with unknown etiology, such as 
demantia. In such diseases, multiple systems or one system or one group of nuclei may 
partly or totally be involved (Loewe et al., 2002). Basically, there are two principal 
pathological processes which determine imaging findings: neuronal or white matter loss 
and deposition of different compounds. The loss of neurons leads to progressive atrophy 
associated with white matter loss and gliosis (Kern & Behl, 2009). 
Nowadays, dementia is a well-known illness with a high incidence in the aged population. 
Clinically, there are a number of neurodegenerative diseases causing dementia, including 
AD, dementia with Lewy bodies, and frontotemporal dementia. Furthermore, dementia 
picture is also present in some neurodegenerative illnesses including Creutzfeldt–Jakob 
disease, Huntington’s disease, progressive supranuclear palsy, multiple system atrophy, 
amyotrophic lateral sclerosis, and Parkinson’s disease (Loewe et al., 2002; Vitali et al., 2008). 
3.1.1 Alzheimer disease (AD) 
AD is well-known progressive neurodegenerative pathology, accounting for around 60% of 
all cases dementia. Clinically, patients with AD have serious cognitive findings related with 
memory, language, such as confusion, poor judgment, language disturbance, agitation, 
withdrawal, and hallucinations (Mohs & Haroutunian, 2002). 
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Fig. 1. T1-weighted MRI scans acquired in coronal (left), axial (center) and sagittal (right) 
planes with 3 T. All images were acquired with a field of view of 25 cm and 256 x 256 
matrix, 1-mm slice thickness. Image was acquired using a turbo field echo sequence, gated 
to achieve an effective TR of >8 ms and TE of 4 ms. Left: Coronal image passing through 
lateral ventricles and temporal lobes. Center: Axial image passing through the lateral 
ventricles and basal ganglia. Right: Mid-sagittal image highlighting the corpus callosum, 
brain stem and cerebellum 
 
Fig. 2. T1-weighted axial MRIs acquired with 1.5 T (left) and 3T (right) MRI scanners. 3T 
MRI was acquired with a field of view of 25 cm and 256 x 256 matrix, 1-mm slice thickness. 
Image was acquired using a turbo field echo sequence, gated to achieve an effective TR of >8 
ms and TE of 4 ms. 1.5T MRI was acquired with field of view of 24 cm, 1.5 mm slice 
thickness. Image was acquired using a spoiled gradient recalled acquisition sequence, gated 
to achieve an effective TR of >35 ms and TE of 15 ms 
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Gross examination of the brain in patients with AD demonstrated an obvious atrophy, 
widening of the sulci, and erosion of the gyri. Histologically, the atrophy of the cortex is 
associated with significant reductions in the numbers of neurons. Macroscopically, the 
weight of the brain is decreased compared to normal controls (Masliah et al., 1991). In a 
previous study using unbiased stereologic sampling techniques, about 50% loss in neurons 
of the superior temporal gyrus has been reported (Gomez-Isla et al., 1996, 1997). In another 
study, 40-46% loss of large neurons in the frontal and temporal cortices of specimens has 
been reported in patients with AD (Terry et al., 1981). In fact, neuronal loss and 
degeneration are not restricted to the cortex; it may be observed in subcortical nuclei such as 
the locus ceruleus, raphe aminergic nuclei (Zweig et al., 1988; Chan-Palay & Asan, 1989), 
and the nucleus basalis of Meynert (Whitehouse et al., 1982). In such cases, synaptic markers 
such as synaptophysin are significantly reduced in the cerebral cortex, especially the frontal 
and parietal cortices and in the hippocampus, with increasing age (Nagy et al., 1995). 
Radiologically, MRI provides understanding of disease progression in AD and other 
dementias. Recently, it has been reported that patients with AD have atrophy in parietal 
lobes, medial temporal lobe and hippocampus on MRI (Loewe et al., 2002, Vitali et al., 2008). 
The parietal lobe atrophy is observed on axial or coronal T1-weighted or FLAIR sequences 
with thinning of the posterior part of the body of the corpus callosum on T1-weighted 
sagittal sequences (Yamauchi et al., 2000). In some studies, decreased hippocampal and 
entorhinal cortex (ERC) volumes in patients with AD were noted (Appel et al., 2009). 
Hippocampal atrophy is observed with thin coronal T1-weighted or FLAIR tomographic 
slices through the medial temporal lobes (Teipel et al., 2003). A lot of quantitative MRI 
studies indicate that white matter hyperintensities correlate with neuropsychological 
functioning in both healthy elderly persons and demented patients (Boone et al., 1992; 
Lopez et al., 1992). Other studies indicate loss of cerebral gray matter (Rusinek et al., 1991), 
hippocampal and parahippocampal atrophy (Kesslak et al., 1991), and lower left amygdala 
and ERC volumes in patients with AD (Pearlson et al., 1992; Obrien, 2007). 
Recently, a longitudinal study demonstrated that most common neuropathologic findings in 
elderly patients are neuritic plaques and neurofibrillary tangles (Mohs &Haroutunian, 2002). 
The presence of these findings before clinical AD diagnosis suggests that in vivo methods 
that directly image these pathognomonic lesions would be useful presymptomatic detection 
technologies (Mohs & Haroutunian, 2002).   
3.1.2 Frontotemporal demantia (FTD) 
Frontotemporal demantia (FTD) is as common a cause of dementia. In particular, volumes of 
some regions of the frontal lobe (the ventromedial and posterior orbital regions of the 
frontal lobe), the cingulate cortex, and the insula are reduced in patients with the FTD, 
compared with those of both AD patients and age-matched controls. This feature 
differentiates this illness from AD as these areas are relatively spared in the latter disease 
(Rosen et al., 2002). In patients with the semantic variant of FTD, there is a relative 
preservation of frontal lobe volumes but marked loss of volumes in the temporal lobes 
(Rosen et al,. 2005, 2006). In clinical practice, FTD includes a group of neurodegenerative 
diseases characterized by focal atrophy of frontal and anterior temporal lobes and non-AD 
pathology (Neary et al., 1998; McKhann, 2001; Ratnavalli, 2002).   
3.1.3 Dementia with Lewy bodies (DLB) 
Dementia with Lewy bodies results a diffuse, irreversible and destructive atrophy (Seppi & 
Schocke, 2005). Measurement of brain volume to predict atrophy using MRI may be used as 
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a predicter for outcome in different neurodegenerative diseases such as AD. There are a lot 
of biologic factors influencing cerebral volume measurement such as inflammation and 
edema, cerebrovascular disease, chronic alcoholism and normal aging (Ron et al., 1982; 
Molyneux et al., 2000).  
3.2 Multiple Sclerosis (MS) 
In cases with MS, various measurement techniques revealed atrophy of brain and spinal 
cord, axonal loss, and Wallerian degeneration (Sharma et al., 2004). Recent studies show that 
the MS is a destructive disease process and whole-brain atrophy is a valuable marker for the 
progression of the disease (Sharma et al., 2004).  
3.3 Medial temporal lobe epilepsy (MTLE) 
In patients with medial temporal lobe epilepsy (MTLE), the atrophy of the hippocampus is 
often observed on routine MRI. Recently, it has been reported that automatic morphometry 
can be used as a clinical tool to provide a quantifiable estimation of of hippocampal atrophy 
in patients with MTLE (Bonilha et al., 2009). Most recently, Henry et al. (2011) suggested 
that ultrahigh-field-strength MRI revealed prominent atrophy of Ammon horn in patients 
with MTLE and hippocampal sclerosis. 
3.4 Ageing 
With increasing age, there are some volumetric changes in the gray matter structures of the 
temporal lobe, amygdale, and hippocampus, a critical structure for memory in AD, but they 
are heterogenous, with some regions showing more atrophic changes than others 
(O’Sullivan, 2009). Recently, it has been reported that it is possible to differentiate ageing 
from AD with 87% accuracy (Likeman et al., 2005; O’Sullivan, 2009). Some volumetric 
studies demonstrated that changes in white matter regions provide an early and accurate 
diagnosis (Davatzikos et al., 2008). 
4. Methods for volume estimation  
4.1 Manual, automated and semiautomated methods for volume estimation 
Use of imaging methods for quantitive volume estimation such as manual, semi-automated 
and automated methods can provide the capability to reliably detect and identify general 
and specific structural abnormalities of the brain. Use of these methods can aid to diagnose 
some specific neurological diseases and facilitate monitoring of the progression of the 
disease. Quantative measures of the brain atrophy can be clinically relevant and much work 
has been carried out to establish diagnosis of AD (Furlong, 2008).  
At present, a number of manual, semi-automated and automated methods based on 
conventional MRI are available for measuring whole or regional brain volume. Ideally, the 
technique for measuring tissue volume should be reproducible, sensitive to subtle 
modifications, practical, fast and correct. Theoretically, many factors may affect the 
quantification of brain atrophy using segmentation methods, such as the pulse sequence and 
the resolution parameters chosen for the acquisition (Horsfield et al., 2003; Sharma et al., 
2004).  
One of these most important factors is slice thickness. The use of thin slice helps to reduce 
the partial volume effect and consequently permits a better estimation of tissue volumes. 
Moreover, high contrast makes segmentation between the different cerebral compartments 
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easier. Depending on the compartment of interest, tissue contrast can be chosen such as 
CSF/parenchyma or gray/white matter (Grassiot et al., 2009). There are many different 
segmentation methods for estimating brain volume using manual or automated techniques. 
Flippi et al. (1998) used manual technique for whole brain volume with MS. Although the 
manual tracing of brain structure allows brain volume to be estimated, this technique is a 
time consuming method (Flippi et al., 1998).  
Semi-automated techniques, quicker and more reproducible, use various algorithms of brain 
segmentation from 3D volume (Horsfield et al., 2003). For both semi-automated and 
automated methods, however, manual defining of brain structures is necessary. In semi-
automated methods, manual marking of some anatomical landmarks and an automatic 
segmentation of the region of interest (ROI) are required, while automated methods are 
completely user-independent in the determination of various parameters such as brain size 
and shape. Importantly, experienced raters with detailed knowledge of neuroanatomy are 
necessary for manual techniques and correct estimations related to the neuroanatomical ROI 
are possible (Keller & Roberts, 2009). 
Automated and semi-automated methods for segmentation and quantification of the brain 
are used in most studies. More recently, various image analysis tools have been developed, 
including both automated and semi-automated algorithms, relying on either raw or 
normalized brain volume assessments (Pelletier et al., 2004). Several previous studies have 
described automatic segmentation methods using MRIs. Calmon & Roberts (2000) reported 
a segmentation method for the lateral ventricles on coronal MR images. Stokking et al. 
(2000) described the development of a morphology-based brain segmentation method for 
fully automatic segmentation of the brain using T1-weighted MRI data. Webb et al. (1999) 
reported a method of automatic detection of the hippocampus with atrophy. These methods 
each segmented one target object on each MRI obtained by different sequences. Therefore, 
these methods could not segment two or more objects simultaneously on MRIs obtained by 
a single sequence. 
There are two primary methods for manual quantification of brain compartment volume 
from MRIs, namely stereology in conjunction with point counting and planimetric methods 
or manual tracing (Acer et al., 2007; Keller & Roberts, 2009). Authors used manual tracing of 
brain boundaries from MRI scans using various softwares such as Analyze (Biomedical 
Imaging Resource, Mayo Foundation), BRAINS (Iowa Mental Health Clinical Research 
Center 2008), and FreeSurfer (Dale et al., 1999; Fischl et al., 1999; Fischl et al., 2002). Manual 
techniques such as planimetry or tracing methods require the investigator to delineate a 
brain region based on reliable anatomical landmarks, whilst the software package provides 
information on volume. Tracing methods require the investigator to trace the brain ROI 
using a mouse driven cursor throughout a defined number of MRI sections (Keller & 
Roberts, 2009). The cut surface areas, determined by pixel counting within the traced region, 
are summed and multiplied by the distance between the consecutive sections traced to 
estimate the total volume. Although tracing methods represent the most commonly used 
tool to estimate brain structure volume on MRIs, there are some drawbacks associated this 
technique (Geuze et al., 2005). Firstly, the time taken to perform manual tracing or manual 
segmentation methods is significantly longer than stereological point counting methods 
(Acer et al., 2007, 2008; Keller & Roberts, 2009). Secondly, tracing and manual segmentation 
methods suffer from the risk of “hand wobble” during the delineation of ROI boundaries on 
MRI sections (Keller & Roberts, 2009).  
The measurement of rates of change requires volume quantification. In general, manual or 
semi-automated methods have been employed for volume quantification on structural brain 
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MRIs, but they are generally severely limited in practicality and reliability. For example, a 
high-resolution 3D brain MRI data set can contain more than 100 slices to cover an entire 
brain (Keller & Roberts, 2009). Manually delineating tissue boundaries for volumetric 
measurement can be a tedious and demanding process because of the presence of the 
extremely complex convoluted structures of the brain. Manual tracing is also well-known to 
be associated with large subjective variability and low reproducibility. As a result, methods 
with better reproducibility and higher precision are required for measuring subtle neuro-
anatomic changes and these methods are likely to be based on computerized approaches. 
FreeSurfer is freely available on the World Wide Web (www or commonly known as the 
Web), it has been widely used in the neuroimaging field. At present, fully automated 
methods are most often used. Fully automated or semi-automated methods can be applied 
to a specific ROI (such as the thalamus or the hippocampus) to obtain a regional brain 
volume (Houtchens et al., 2007). 
4.2 Brain segmentation 
Brain tissue segmentation of MRIs means to specify the tissue type for each pixel or voxel in 
a 2D or 3D data set, respectively, on the basis of information available from both MRIs and 
the prior knowledge of the brain. It is an important preprocessing step in many medical 
research and clinical applications, such as quantification of tissue volume, visualization and 
analysis of anatomical structures, multimodality fusion and registration, functional brain 
mapping, detection of pathology, surgical planning, surgical navigation, and brain 
substructure segmentation (Suri et al., 2002). So far, various segmentation techniques such 
as Gaussian mixture models (Ashburner & Friston, 2005), discriminant analysis (Amato et 
al., 2003), k-nearest neighbor classification (Mohamed et al., 1999), and fuzzy c-means 
clustering (Pham & Prince, 1999; Suckling et al., 1999; Ahmed et al., 2002; Zhou & Bai, 2007) 
were used to determine gray and white matter volume. Most recently, it has been reported 
that "fuzzy" cluster or classifier approaches were found to have a high reliability, accuracy, 
and validity (Herndon, 1998). 
4.3 Image processing and segmentation  
Today, medical image processing and segmentation are used to improve the quality of 
diagnosis. We can calculate the cortical volume and surface area using the Fuzzy C-Means 
algorithm as a semi-automated segmentation method as described in Figure 3. 
Firstly, T1-weighted MRIs are normalized using registration algorithms. Following 
normalization process, we obtain brain contour to calculate volume and surface area of the 
brain using image working algorithms. Images of brain are cleared brain contour using 
morphological image processing. This method involves two major steps and final 
segmented images result from separation of parenchyma for brain volume and surrounding 
line for cortical surface area of the brain (Tosun et al., 2004; Ueda et al., 2009; Brouwer et al., 
2010; Lui et al., 2010)  (Fig. 4).   
4.4 Stereological approaches 
In general, stereological methods provide quantitative data on 3D structures using 2D 
images. Stereological methods have been widely applied on MRIs to estimate geometric 
variables, such as volume and surface area, and various internal brain compartments. The 
volume of internal brain structure can be obtained using the Cavalieri principle of 
stereologic approaches.  
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Fig. 3. Brain image segmentation blocks (Nakamura & Fisher, 2009) 
 
 
Fig. 4. Segmentation called the Fuzzy C. Left: Original T1-weighted image. Center: Masking 
and removal of artifacts the outer contour of the brain. Right: Contour of segmented image 
is outlined 
4.4.1 Point-counting method 
The Cavalieri method in combination with point counting requires beginning from a uniform 
random starting within the sectioning interval, a structure of interest is exhaustively 
sectioned with a series of parallel plane probes a constant distant apart. An unbiased 
estimate of volume is obtained by multiplying the total area of all sections through the 
structure by sectioning interval t as following: 
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 ( )1 2 .. nestV t a a a= × + + +  (1) 
where a1,a2…an show the section areas and t is the sectioning interval (Roberts et al., 2000; 
García-Fiñana et al., 2003).  
The point counting method involves overlying each MRI with a regular grid of test points. 
After each superimposition, the number of test points hitting the structure of interest is 
counted on each section and we can estimate volume following formula: 
 ( )1 2 .. naestV t p p p
p
⎛ ⎞= × × + + +⎜ ⎟⎝ ⎠
 (2) 
where p1, p2,…..pn show point counts and a/p represent the area associated with each test 
point. To avoid bias, the position of the test system should be uniform randomly (Roberts et 
al., 2000; García-Fiñana et al., 2003).  
In any case, the following formula (Eq.3) can be used for volume estimation from MRIs of 





V pc t p
sl
×⎡ ⎤= × ×⎢ ⎥⎣ ⎦ ∑  (3) 
where ‘t’ is the section thickness, ‘su’ the scale unit of the printed film, ‘d’ the distance 
between the test points of the grid, ‘sl’ the measured length of the scale printed on the film 
and ‘Σp’ is the total number of points hitting the sectioned cut surface areas of the related 
structures such as the cerebrum. 
From stereological point of view, planimetry and point-counting are two different methods 
for estimating volume based on the Cavalieri principle. The Cavalieri principle may be used 
for estimating the volume of brain and substructures such as hypocampus, amygdale and 
thalamus. Therefore, a random beginning is necessary and the object is cut into slices of a 
known and fixed thickness. The volume is estimated by multiplying the distance between 
the slices by the total cut area of the structures are under investigation. The cut area of the 
structures may be estimated by point-counting or planimetry. Nevertheless, the Cavalieri 
principle in combination with point-counting is ideal for estimating total volumes of various 
brain and any compartments. Keller et al. (2002, 2007, 2008) and Acer et al. (2008, 2010) have 
previously applied this technique to obtain volume estimations of various brain structures 
such as Broca’s area, hippocampus, ventricles, cerebral hemisphere, and cerebellum. In these 
studies, a set of parallel and equidistant MRIs of the brain is randomly selected, and the ROI 
is directly estimated on each image by randomly superimposing a grid of points, and 
subsequently, counting the number of points that fall within the ROI (Keller et al., 2002, 
2007, 2008; Acer et al., 2008, 2010). 
Stereology in combination with point counting has an advantage related with the time taken 
to estimate volume of brain structures on MRIs. Compared with manual tracing or 
segmentation methods, this technique is much more time efficient. Another advantage of 
stereology in combination with point counting is the prediction of the coefficient of error 
(CE) so that it may be used to identify the optimal parameters of sampling needed to 
achieve a given precision such as we need the number of MRI sections and the density of the 
point grid.  
Importantly, the stereological approach provides an opportunity for the investigator making 
appropriate changes on their sampling or estimating procedures. Therefore, the Cavalieri 
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method gives a CE of estimation for each volume assessment. Thus, an investigator may 
easily observe the potential variability in any given volume measurement. It may cause 
some problems in accuracy and hence interpretation in the presence of high CE for these 
measurements. If too few slices or too few points are taken for volume estimation, it is 
possible to encounter with such problems. The investigator is eligible to change the spacing 
of points in the grid or the number of slices available in any CT or MR study to provide a 
reasonable CE value. More importantly, an appropriate grid size and the number of slices 
required for volume estimation of an object is crucial at the beginning, obviating the need to 
calculate the CE value for repeated sessions (Sahin et al., 2003; Acer et al., 2008).  
In the stereological method, continuous investigator computer interaction is necessary 
because all points intersecting the cerebral hemispheres should be removed or marked on 
consecutive MRI sections. For the reliable measurement of each brain structure using 
stereology in conjunction with point counting, the stereological parameters like grid size 
and slice gap should be optimized by counting at least 200 points per structure. In a 
previous study investigating the cerebral hemispheres, a grid size of 15 and slice gap of 
every 15 sections results in approximately 200 points being counted per hemisphere on 
frequently acquired 3D T1-weighted images (Mackay et al., 1998; Cowell et al., 2007), and it 
achieves a CE lower than the optimal 5% (Roberts et al., 2000). It has been reported that 
stereological volume estimation of a cerebral hemisphere using the Windows based software 
packages (EASYMEASURE and MEASURE) takes approximately 10 minutes (Keller & 
Roberts, 2009). 
Stereological point counting method involves the random placement of a grid with 
sufficient resolution in 2D or 3D over the structure of interest and counting the points 
overlying the ROI. For this method, the requirements are a grid encompassing the region or 
structure completely, the structure placed with a grid randomly, and an adequate number of 
points counted on an adequate number of slices. Thus, the stereological point counting 
approach is very efficient and statistically sound, in addition to providing a CE of the 
measurement of the volume of the structure of interest.  
4.4.2 Worked example for point-counting technique 
According to point-counting technique, a square grid of test points is positioned on each 
MRI section, and all points hitting the cerebrum are counted (Fig. 5). 










V pc t p
sl
V cm
×⎡ ⎤= × ×⎢ ⎥⎣ ⎦
×⎡ ⎤= × × =⎢ ⎥⎣ ⎦
∑
 (3) 
In the Cavalieri method in combination with point-counting technique using MRI sections, 
relationship between numbers of section and counts is given in Table 1. 
 
Section number 1 2 3 4 5 6 7 8 Total Point Counts 
Point number 42 72 122 132 129 116 115 68 796 
Table 1. Relationship between numbers of section and counts of point in point-counting 
technique 
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Fig. 5. Acoronal MRI series with a point-counting on it for the estimation of the cerebral 
volume from first to last section (T=1.6 cm) 
4.4.3 Error prediction for point counting technique 
The error predictors given below originate from the recent literature (García-Fiñana & Cruz-
Orive, 2000; Garcia Finana, 2006; Garcia Finana et al., 2009). In particular, the estimation of 
volume and variance of the volume estimate for the cerebral volume are calculated as 
follows. 
An unbiased estimator of Q can be constructed from a sample of equidistant observations of 
f, with a distance T apart, as follows: 
 ( ) ( )0 1 2ˆ ...T n
k Z
Q T f x kT T f f f
∈
= + = + +∑  (4) 
where x0 is a uniform random variable in the interval [0,T) and {f1, f2, … , fn} is the set of 
equidistant observations of f at the sampling points which lie in [a, b]. In many applications, 
Q represents the volume of a structure and f(x) is the area of the intersection between the 
structure and a plane that is perpendicular to a given sampling axis at the point of abscissa x 
(García-Fiñana & Cruz-Orive, 2000; Garcia Finana, 2006; Garcia Finana et al., 2009).   
This data sample represents the area of cerebrum in cm2 on a total of 8 MRI sections a 
distance T = 1.6 cm apart (Table 1). 
To estimate Var ( ˆ TQ ) via Eq. (5) we have to calculate first α(q), C0, C1, C2 and C4 (Table 2). 
 ( ) ( )( ) [ ]20 1 2ˆvar 3 4      0,1TQ q C C C T qα= − + ∈  (5) 
From Eq. (6), we have: 
 
1
,      1,  2,  ... - 1
n k
k i i k
i




=∑  (6) 
Equation (5) is an extended version of the variance estimator given in (García-Fiñana & 
Cruz-Orive, 2004).  
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Section (i) Pi Pi2 Pi.Pi+1 Pi.Pi+2 Pi.Pi+4 
1 42 1764 3024 5124 5418 
2 72 5184 8784 9504 8352 
3 122 14884 16104 15738 14030 
4 132 17424 17028 15312 8976 
5 129 16641 14964 14835 0 
6 116 13456 13340 7888 0 
7 115 13225 7820 0 0 
8 68 4624 0 0 0 
  87202 81064 68401 36776 
Total 796 C0 C1 C2 C4 
Table 2. Calculation of the constants C0, C1, C2, C4 












⎧ ⎫⎡ ⎤− +⎪ ⎪= −⎢ ⎥⎨ ⎬− +⎢ ⎥⎪ ⎪⎣ ⎦⎩ ⎭
 (7) 
1 3 87202 4 68401 36776 1
0, log 0.53
2log 2 3 87202 4 81064 68401 2
q
⎧ ⎫× − × +⎪ ⎪⎡ ⎤= − =⎨ ⎬⎢ ⎥× − × +⎣ ⎦⎪ ⎪⎩ ⎭
 
We apply Eq. (7) with α = 0.53. 
The coefficient α(q) has the following expression (Eq.8): 
 ( ) ( ) ( ) ( )( ) ( ) [ ]2 2 2 1
2 2 2 2 cos





ζ πα π + −
Γ + += ∈−  (8) 








Γ= =−  





var( ) ( )(3 4 )









= × × − × + ×
=
 (9) 
We predict the value of CE;  
( ) 9.2 /856.9 0.0103 1.03%TCE Q = = =  
In our studies, we calculate the CE values as predictive using the R program. First, by using 
the statistical package R, codes are developed to calculate the contribution to the predictive 
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CE (García-Fiñana & Cruze-Orive, 2004). A value of CE lower than 5% is in the acceptable 
range (Gundersen & Jensen, 1987, and 1999; Sahin et al., 2003). In addition, it is very 
important to note that an appropriate grid size and the number of slices required for volume 
estimation of an object is crucial at the beginning.  
5. Conclusion  
In conlusion, MRI may help to specify the cause of the disease such as the brain atrophy, if a 
kind of neurodegenerative dissease is present. Unfortunately, however, conventional MRI 
study not give subsutructural detailed information about cellular and molecular 
organisation of the brain tissue. On the other hand, it is also possible to define the etiologies 
of the pathologies using new functional MRI methods, such as diffusion weighted imaging 
and MRS. Future advances in functional and anatomic neuroimaging techniques provide 
further insights into certain neurodegenerative disseases of the brain. A combination of 
different neuroimaging techniques and atrophy correction through MRI, PET and SPECT 
superimposition may demonstrate functional and morphological features of the brain tissue. 
In similar to MRI, PET and SPECT are useful in the diagnosis of some neurodegenerative 
diseases.  
By using MRI, the estimation of the brain volume is a well-known entity for the 
determination of the brain atrophy. Several different methods such as segmentation 
techniques are available for the estimation of the brain volume, but there are only a few 
stereological studies using point-counting and planimetric methods. Recently, the Cavalieri 
principle in combination with point-counting has become popular in the understanding of 
the pathologies of brain morphology. There is no doubt that determination of the brain 
atrophy using MRI will be useful in understanding of neurodegenerative diseases, 
monitoring of disease progression, and treatment of such patients. In conclusion, the 
Cavalieri principle in combination with point-counting is an ideal method for the estimation 
of total volume of the brain or any of its compartment for the diagnosis of atrophic 
neurodegenerative diseases. 
Nevertheless, further combinations of new imaging techniques with different methods for 
volume estimation using a combination of different neuroimaging techniques are needed for 
early diagnosis and monitorization of course of the disease. It is important to know that 
these techniques for volume estimation must be reproducible and reliable. The greater 
accuracy of imaging methods in detection of early neurodegenerative disseases will result in 
early optimal treatment to delay further cognitive decline.  
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